BD (Becton, Dickinson and Company) recently expanded its European infectious disease diagnostics portfolio after IVDR ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its respiratory and sexually ...

BD announced the expansion of its respiratory and sexually transmitted infection diagnostics offerings in Europe following In Vitro Diagnostic ...

The president of BD’s life sciences division, Dave Hickey, is officially planning his retirement, with the calendar marked for July 1. Hickey has overseen BD’s portfolio of scientific research tools ...

FRANKLIN LAKES, N.J. and AUSTIN, Texas, Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, and Babson Diagnostics, a science-first ...

Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to ...

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation "New BD," built on momentum of BD 2025 ...

Nearly three years after Beckon Dickinson spun off its diabetes care unit, the Franklin Lakes-based global medical technology company aims to slim down even further to focus on its core business. As ...

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX), and health care technology company Babson Diagnostics, announced Tuesday an expansion of fingertip blood collection and ...

Waters Corporation (NYSE: WAT) and BD (Becton, Dickinson and Company) (NYSE: BDX) today announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters, ...